CSIMarket Company Name, Ticker, Suppliers, else..


Zynerba Pharmaceuticals Inc   (NASDAQ: ZYNE)
Other Ticker:  
 

Zynerba Pharmaceuticals Inc

ZYNE's Fundamental analysis



Zynerba Pharmaceuticals Inc 's sales fell in the second quarter of 2023 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.1 %

Zynerba Pharmaceuticals Inc net loss increased from $-10 millions, to $-11 millions in second quarter of 2023,

• More on ZYNE's Growth


Zynerba Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Zynerba Pharmaceuticals Inc realized cash reduction of $ -0.53 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.


• More on ZYNE's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.58

Zynerba Pharmaceuticals Inc
realized net loss in trailing twelve months.

Zynerba Pharmaceuticals Inc realized cash outflow of $ -0.53per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.

Zynerba Pharmaceuticals Inc Price to Book Ratio is at 2.25 lower than Industry Avg. of 35.2. and higher than S&P 500 Avg. of 0.01

• More on ZYNE's Valuation

•  Market Capitalization (Millions $) 65
•  Shares Outstanding (Millions) 50
•  Employees 12
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -38
•  Cash Flow (TTM) (Millions $) -27
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 0.58

•  Market Capitalization (Millions $) 65
•  Shares Outstanding (Millions) 50
•  Employees 12
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -38
•  Cash Flow (TTM) (Millions $) -27
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 3.5
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.39
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com